Home

כמות של בורגונדי רווח ventilator associated pneumonia treatment משוב זיהום עינית

Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical  Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE

Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated  Pneumonia - CHEST
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia - CHEST

Frontiers | Drug Prevention and Control of Ventilator-Associated Pneumonia
Frontiers | Drug Prevention and Control of Ventilator-Associated Pneumonia

Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated  pneumonia due to extensively drug-resistant Pseudomonas aeruginosa |  Scientific Reports
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports

Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical  Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE

Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP
Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP

Biomarker-guided antibiotic stewardship in suspected ventilator-associated  pneumonia (VAPrapid2): a randomised controlled trial and process evaluation  - The Lancet Respiratory Medicine
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including  ventilator-associated pneumonia (REPROVE): a randomised, double-blind,  phase 3 non-inferiority trial - The Lancet Infectious Diseases
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases

Ventilator Associated Pneumonia (VAP) - EMCrit Project
Ventilator Associated Pneumonia (VAP) - EMCrit Project

JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2  Diagnostic Accuracy: Changing the Paradigm?
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?

Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Ventilator-associated pneumonia in adults: a narrative review | SpringerLink

Ventilator-associated pneumonia: The central role of transcolonization -  ScienceDirect
Ventilator-associated pneumonia: The central role of transcolonization - ScienceDirect

Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical  Microbiology and Infection
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection

Grand Rounds Recap 5.30.18 — Taming the SRU
Grand Rounds Recap 5.30.18 — Taming the SRU

REBEL Cast Episode 29: IDSA Pneumonia Update - REBEL EM - Emergency  Medicine Blog
REBEL Cast Episode 29: IDSA Pneumonia Update - REBEL EM - Emergency Medicine Blog

Strategies to reduce non-ventilator-associated hospital-acquired pneumonia:  A systematic review - Infection, Disease & Health
Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: A systematic review - Infection, Disease & Health

Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Ventilator-associated pneumonia in adults: a narrative review | SpringerLink

Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST
Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST

Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention |  Clinical Microbiology Reviews
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews

Ventilator Associated Pneumonia: Evolving Definitions and Preventive  StrategiesDiscussion | Respiratory Care
Ventilator Associated Pneumonia: Evolving Definitions and Preventive StrategiesDiscussion | Respiratory Care

Phase 3 Study for Ventilator-Associated Pneumonia (VAP)
Phase 3 Study for Ventilator-Associated Pneumonia (VAP)

Ventilator-associated pneumonia: A review of the clinically relevant  challenges in diagnosis and prevention | British Journal of Medical  Practitioners
Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners

Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine
Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine

International ERS/ESICM/ESCMID/ALAT guidelines for the management of  hospital-acquired pneumonia and ventilator-associated pneumonia | European  Respiratory Society
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society

Empiric treatment VAP (adults) - UpToDate
Empiric treatment VAP (adults) - UpToDate

How I diagnose and manage ventilator-associated tracheobronchitis |  Medicina Intensiva
How I diagnose and manage ventilator-associated tracheobronchitis | Medicina Intensiva